Loading chat...
MS HC45
Concurrent Resolution
Status
Failed
4/1/2021
Primary Sponsor
Lee Yancey
Click for details
AI Summary
- Urges the FDA to publish good manufacturing guidelines for kratom manufacturers to prevent adulteration and synthetic enhancement of kratom products
- Requires appropriate labeling of kratom products to protect consumers from contaminated or misrepresented kratom
- Notes that HHS rescinded the recommendation to classify kratom as Schedule I due to lack of FDA evidence meeting scheduling criteria
- Expresses concern that banning kratom would force consumers to switch to highly lethal opioids, heroin, and fentanyl, risking thousands of overdose deaths
- Directs copies of the resolution to Mississippi's Congressional Delegation, HHS Secretary, FDA Commissioner, the President, and Capitol Press Corps
Legislative Description
Kratom; urge the United States Food and Drug Administration to regulate.
Last Action
Died On Calendar
4/1/2021
Committee Referrals
Rules3/16/2021
Full Bill Text
No bill text available